The unique ability of the Synthorx platform to incorporate multiple non-natural amino acids offers the potential to study, alter, and improve upon the activity and function of many diverse peptides and proteins – and to produce them at-scale.

We see large opportunities to apply our platform and knowledge to make important, novel medicines that can solve unsolvable biology and treat untreatable diseases.

Here are some possible partnering opportunities. Have another idea? Contact us here.





Infectious Disease, Metabolic Disease, Pain, Inflammation, Oncology

Autoimmune Disease, Inflammation, Oncology


Cystine knot peptides, anti-microbial peptides, dual target agonists

Multi-specific antibodies, antibody fragments and drug conjugates, therapeutic enzymes

Synthorx Advantage

Cost-efficient to synthesize libraries (e.g. macrocycles) and to scale-up difficult proteins (e.g. cystine knots)

We stand alone in our ability to site-specifically incorporate multiple nnAAs

Synthorx Molecules

Unnatural diversity, Cyclization, Novel Chemistries, Half-life Extension, Proteolytic Stability, Recombinant Expression, Production at LARGE SCALE, Cost-effective Libraries for SAR